This inventor holds 3 USPTO granted patents. Top assignee: Novo Nordisk A/s. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Stig Nielsson: Innovator in Enzyme Technology
Introduction
Stig Nielsson is a notable inventor based in Lynge, Denmark. He has made significant contributions to the field of enzyme technology, holding a total of 3 patents. His work primarily focuses on methods for improving enzyme production and crystallization processes.
Latest Patents
Nielsson's latest patents include innovative methods that enhance the efficiency of enzyme production. One of his patents, titled "Selective inactivation of Aspergillus proteases," presents a method for inactivating undesired acid-labile proteases expressed in the culture medium alongside desired enzymes. This method involves incubating the culture medium at pH values below 4.5 and temperatures ranging from 2°C to 75°C for at least 20 seconds. Another significant patent is "Crystallization of a protein with a sulphur salt," which describes a method for crystallizing proteins from a protein-containing solution by treating it with a salt containing a sulphur atom in a lower oxidation state and recovering the protein in crystalline form.
Career Highlights
Stig Nielsson is currently associated with Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in enzyme technology.
Collaborations
Throughout his career, Nielsson has collaborated with esteemed colleagues, including Mads Aage Laustsen and Niels Murmann. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Stig Nielsson's contributions to enzyme technology through his patents and work at Novo Nordisk highlight his role as a significant inventor in the field. His innovative methods continue to influence the industry and pave the way for future advancements.